181 related articles for article (PubMed ID: 2276387)
1. N-acetylation in healthy and diseased children.
Hadasová E; Brysová V; Kadlcáková E
Eur J Clin Pharmacol; 1990; 39(1):43-7. PubMed ID: 2276387
[TBL] [Abstract][Full Text] [Related]
2. Relationship between acetylator phenotype and intensity of the hypoglycaemic effect of a suplhonamide preparation in children with insulin-dependent diabetes.
Hadasová E; Brysová V; Utĕsený J; Macků M
Bratisl Lek Listy; 1991 Dec; 92(12):609-14. PubMed ID: 1806177
[TBL] [Abstract][Full Text] [Related]
3. N-acetylation phenotyping with sulphadimidine in a Turkish population.
Bozkurt A; Basci NE; Kalan S; Tuncer M; Kayaalp SO
Eur J Clin Pharmacol; 1990; 38(1):53-6. PubMed ID: 2328748
[TBL] [Abstract][Full Text] [Related]
4. Genetically determined variability in acetylation and oxidation. Therapeutic implications.
Clark DW
Drugs; 1985 Apr; 29(4):342-75. PubMed ID: 2859977
[TBL] [Abstract][Full Text] [Related]
5. Association of microalbuminuria with slow acetylator phenotype in type 1 diabetes mellitus.
Madácsy L; Szórády I; Sánta A; Barkai L; Vámosi I
Child Nephrol Urol; 1992; 12(4):192-6. PubMed ID: 1473091
[TBL] [Abstract][Full Text] [Related]
6. The relationship between the metabolism of procainamide and sulfamethazine.
Giardina E-GV ; Stein RM; Bigger JT
Circulation; 1977 Feb; 55(2):388-94. PubMed ID: 832354
[TBL] [Abstract][Full Text] [Related]
7. Acetylator phenotype and congenital malformations.
Stoll C; Roth MP; Dott B; Doumit N; Alembik Y; Welsch M; Imbs JL
Eur J Clin Pharmacol; 1989; 36(2):151-3. PubMed ID: 2721540
[TBL] [Abstract][Full Text] [Related]
8. Acetylator status of kwashiorkor children in Ibadan (south-west Nigeria).
Jeyakumar LH; Arowoshegbe UA; Akinyinka OO; Akinbami FO; Bababunmi EA
Eur J Drug Metab Pharmacokinet; 1990; 15(1):57-62. PubMed ID: 2384118
[TBL] [Abstract][Full Text] [Related]
9. Acetylator polymorphism in Parkinson's disease.
Ladero JM; Jimenez FJ; Benitez J; Fernandez-Gundin MJ; Martinez C; Llerena A; Cobaleda J; Muñoz JJ
Eur J Clin Pharmacol; 1989; 37(4):391-3. PubMed ID: 2598972
[TBL] [Abstract][Full Text] [Related]
10. Effect of concomitant isoniazid administration on determination of acetylator phenotype by sulphadimidine.
Zysset T; Peretti E
Eur J Clin Pharmacol; 1986; 30(4):463-6. PubMed ID: 3743623
[TBL] [Abstract][Full Text] [Related]
11. The effect of glucose on acetylation status.
Suhardjono D; Boutagy J; Shenfield GM
Br J Clin Pharmacol; 1986 Oct; 22(4):401-8. PubMed ID: 3768255
[TBL] [Abstract][Full Text] [Related]
12. Polymorphic acetylation of sulphadimidine in normal and uraemic man.
Talseth T; Landmark KH
Eur J Clin Pharmacol; 1977; 11(1):33-6. PubMed ID: 832655
[TBL] [Abstract][Full Text] [Related]
13. N-acetylation and oxidative capacity in aged volunteers determined with sulfamethazine and antipyrine.
Siegmund W; Franke G; Wulkow R; Hanke W; Thonack R
Int J Clin Pharmacol Ther Toxicol; 1991 Dec; 29(12):469-73. PubMed ID: 1813431
[TBL] [Abstract][Full Text] [Related]
14. Drug acetylation and expression of lupus erythematosus.
Marsden JR; Mason GG; Coburn PR; Rawlins MD; Shuster S
Eur J Clin Pharmacol; 1985; 28(4):387-90. PubMed ID: 4029245
[TBL] [Abstract][Full Text] [Related]
15. Polymorphic acetylation of sulphamethazine in a Zimbabwe population.
Nhachi CF
J Med Genet; 1988 Jan; 25(1):29-31. PubMed ID: 3351888
[TBL] [Abstract][Full Text] [Related]
16. Influence of acetylator phenotype on the pharmacokinetics of a new vasodilator antihypertensive, endralazine.
Reece PA; Cozamanis I; Zacest R
Eur J Clin Pharmacol; 1982; 23(6):523-7. PubMed ID: 7160421
[TBL] [Abstract][Full Text] [Related]
17. Kinetic discrimination of three sulfamethazine acetylation phenotypes.
Chapron DJ; Kramer PA; Mercik SA
Clin Pharmacol Ther; 1980 Jan; 27(1):104-13. PubMed ID: 7351110
[TBL] [Abstract][Full Text] [Related]
18. Sulphamethoxazole acetylation in fast and slow acetylators.
Bozkurt A; Basci NE; Isimer A; Tuncer M; Erdal R; Kayaalp SO
Int J Clin Pharmacol Ther Toxicol; 1990 Apr; 28(4):164-6. PubMed ID: 2338369
[TBL] [Abstract][Full Text] [Related]
19. Comparison between serum isonicotinic acid hydrazide (INH) levels and urinary sulfadimidine (sulfamethazine) acetylation as predictors of INH acetylator status.
Seth V; Seth SD; Beotra A; Singh U
Dev Pharmacol Ther; 1988; 11(1):32-6. PubMed ID: 3383719
[TBL] [Abstract][Full Text] [Related]
20. Polymorphic acetylation of sulphamethazine in man: acetylator phenotype in sicklers and non-sicklers.
Jeyakumar LH; French MR
Toxicol Lett; 1980 Sep; 6(4-5):263-5. PubMed ID: 7423555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
